Target Trial Emulation: Glucagon-Like Peptide 1 Receptor Agonist, Sodium-Glucose Cotransporter-2 Inhibitors, Dipeptidyl Peptidase-4 Inhibitors for Kidney Outcome Prevention
GLP1RA and SGLT2i as add-on diabetes treatment was associated with lower composite and individual outcomes of kidney event and death. The association was similar across subgroups highlighting the value in primary prevention among older populations.
Authors
- Tom A. Elasy (ORCID: https://orcid.org/0000-0002-1651-8387)
- Amber J. Hackstadt (ORCID: https://orcid.org/0000-0002-0164-6589)
- Christianne L. Roumie (ORCID: https://orcid.org/0000-0002-6555-2055)
- Cole Beck
- Robert A. Greevy
- Adriana Hung
Institutions
- Vanderbilt University (US)
- VA Tennessee Valley Healthcare System (US)
- Vanderbilt University Medical Center (US)
Publication Details
- Journal
- Clinical Journal of the American Society of Nephrology
- Published
- 2026-03-26
- DOI
- https://doi.org/10.2215/cjn.0000001033
- Primary Topic
- Diabetes Treatment and Management
- Type
- article
- Field-Weighted Citation Impact
- 0.00